SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-14-000017
Filing Date
2014-08-05
Accepted
2014-08-05 16:06:09
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-2014630x10q.htm 10-Q 1770801
2 TERMINATION AND TRANSITION AGREEMENT amgn-ex1055_2014630xq2.htm EX-10.55 2083574
3 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_2014630xq2.htm EX-31 23638
4 SECTION 1350 CERTIFICATIONS amgn-ex32_2014630xq2.htm EX-32 10593
  Complete submission text file 0000318154-14-000017.txt   15346499

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT amgn-20140630.xml EX-101.INS 2722718
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20140630.xsd EX-101.SCH 62267
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20140630_cal.xml EX-101.CAL 98074
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20140630_def.xml EX-101.DEF 295210
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20140630_lab.xml EX-101.LAB 741646
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20140630_pre.xml EX-101.PRE 448632
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 141016206
SIC: 2836 Biological Products, (No Diagnostic Substances)